Jakap Koo

Insider Reports History

Location
2 East Broad Street, 2 Nd Floor, Hopewell, NJ
Signature
/s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jakap Koo:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Apimeds Pharmaceuticals US, Inc. Director Common Stock, par value $0.01 per share 644K May 12, 2025 Direct
Apimeds Pharmaceuticals US, Inc. Director Stock Option (right to buy) 10K Nov 11, 2025 Direct

Insider Reports Filed by Jakap Koo

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APUS Apimeds Pharmaceuticals US, Inc. Nov 11, 2025 1 $0 4 Nov 13, 2025 Director
APUS Apimeds Pharmaceuticals US, Inc. Oct 15, 2025 1 $0 4 Oct 17, 2025 Director
APUS Apimeds Pharmaceuticals US, Inc. May 16, 2025 1 $0 4 May 20, 2025 Director
APUS Apimeds Pharmaceuticals US, Inc. May 12, 2025 1 $56.7K 4 May 14, 2025 Director
APUS Apimeds Pharmaceuticals US, Inc. Mar 4, 2025 0 $0 3 May 8, 2025 Director